Clinical trial
Imuran Dosing in Crohn's Disease Study
NCT00113503 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Terminated
Key facts
| NCT number | NCT00113503 |
|---|---|
| Title | Imuran Dosing in Crohn's Disease Study |
| Official title | A Multi-site Trial of Azathioprine Dosing in Crohn's Disease |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Collaborators | Prometheus Laboratories Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Crohn's Disease |
| Intervention type | Drug |
| Interventions | Azathioprine weight-based dose, Azathioprine individualised dose |
| Enrollment | 50 |
| Start date | Jul 1, 2005 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Jun 9, 2005 |
| Last update posted | Oct 6, 2017 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: